Philip Probert

Philip is Technology Lead at CPI Biologics, managing a team encompassing the upstream, downstream, analytical and MSAT groups. In his role he oversees and supports resourcing and delivery of a challenging commercial and collaborative project portfolio. He has experience of technical leadership of projects encompassing a diverse range of product types including recombinant proteins, monoclonal antibodies, viral vectors and nucleic acids, working from bench to pilot scale expressed in mammalian, microbial and/or cell-free systems. This includes high throughput process development, design of experiment approaches to process optimisation and development and exploitation of molecular methods including the use of next-generation sequencing and bioinformatics to inform production clone selection.

Prior to joining CPI, he was a research associate at Newcastle University where he developed and used a range of methodologies including sequencing, bioanalytical and chemical assays to identify novel environmental contaminants. Prior to this he achieved his doctorate for his thesis which developed, validated and published novel in-vitro and in-vivo toxicology models at Newcastle University.